Mentorship in patient-oriented research to improve health of older adults with diabetes
Active Project Grant Awarded Last action
- Award ID
- K24AG098115
- Recipient
-
University Of Maryland, Baltimore UEI Z9CRZKD42ZT1
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $210,405
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date 2% complete
- Place of performance
- Baltimore, MD 21201, USA
Award details come from USAspending.gov.
About this award
The National Institute on Aging awarded the University of Maryland, Baltimore $210,405 on September 15, 2026, under the Aging Research program (CFDA 93.866) to support mentorship in patient-oriented research improving health outcomes for older adults with type 2 diabetes.
The award funds a Midcareer Investigator Award in Patient-Oriented Research (K24) with dual objectives: to provide Dr. McCoy with time and resources to mentor and support clinical investigators developing careers in patient-oriented research focused on older adults with type 2 diabetes, and to generate evidence on optimal type 2 diabetes treatment in older adults and on the distribution and health impacts of multilevel, multidimensional drivers of health in this heterogeneous population. The mentees will conduct impactful, distinct research investigations using a range of research methods within an interdisciplinary research team leveraging Dr. McCoy's research infrastructure.
Research and mentoring activities will be conducted at the University of Maryland School of Medicine in Baltimore, Maryland. The period of performance runs from the award date through June 30, 2031.
The award targets the growing population of older adults with type 2 diabetes—more than 16.5 million U.S. adults aged 65 and older—who experience potentially preventable disability, morbidity, and mortality despite advances in available pharmacotherapies. The project addresses the need for rigorous patient-oriented research on optimized pharmacotherapy selection, accessible high-quality care delivery, and mitigation of adverse social determinants of health in this population.
Description
- Abstract
- More than 16.5 million older adults, or 29.2% of U.S. Adults ≥65 years, are living with diabetes. Older adults with type 2 diabetes (T2D) are a highly heterogeneous population, with wide variation in clinical complexity, functional status, and available personal, community, and clinical supports, which collectively impact their capacity for self- management, access to healthcare, and health. Reducing the disability, morbidity, and mortality caused by T2D in older adults therefore requires optimized selection of T2D pharmacotherapy, accessible delivery of high quality T2D care, and mitigation of adverse social determinants of health (sdoh). The growing population of older adults with T2D and the stagnant and unacceptably high rates of potentially preventable diabetes-related disability, morbidity, and mortality despite major advances in available T2D pharmacotherapies signal the need for rigorous patient-oriented research focused on T2D in older adults. The dual objectives of this midcareer investigator award in patient-oriented research (K24) are: 1) to provide DR. Mccoy with the time and resources necessary to mentor and support promising clinical investigators poised for careers in patient-oriented research and committed to improving the health of older adults with T2D; and 2) to generate essential evidence on the optimal treatment of T2D in older adults (aims 1-2) and on the distribution and health impacts of multi-level, multi-dimensional drivers of health in this highly heterogeneous population (aim 3), with opportunities for mentees to conduct impactful, distinct research investigations using a wide range of research methods, leveraging DR. Mccoy's robust research infrastructure, and as part of a thriving interdisciplinary research team. The proposal's research and mentoring activities will be conducted at the university of maryland school of medicine, which has a strong history of training physician scientists and clinical investigators in patient-oriented research, a well-developed infrastructure for education and research, and a large pool of talented trainees and junior faculty from different disciplines and backgrounds. DR. Mccoy's interdisciplinary NIH- and pcori-funded research program is ideally suited to support mentees across the university of maryland system by providing access to rich real-world data; strong partnerships across the clinical practice to facilitate primary data collection; support of an exceptional team of collaborators and methodologists with complementary expertise in advanced causal inference methods, geospatial analyses, implementation science, and pragmatic trials; extensive career development and training opportunities; and a strong track record of dedicated and supportive mentorship. This proposal aims to strengthen DR. Mccoy's mentorship capabilities and generate novel avenues for her mentees to succeed in bolstering their independent research careers, while simultaneously furthering DR. Mccoy's continued career development as a physician scientist, mentor, and leader in patient-oriented research in T2D in older adults.
Quick answers
Who received award K24AG098115?
K24AG098115 was awarded to University Of Maryland, Baltimore by National Institute on Aging (National Institutes of Health) on September 15, 2026.
How much is award K24AG098115 worth?
$210,405 has been obligated on K24AG098115.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award